CB Therapeutics logo

CB Therapeutics

CB Therapeutics produces high value molecules, compounds and rare ingredients with novel, proprietary SynBio platforms.

15 employees · est. 2015 · Carlsbad, United States

VS
Psylo logo

Psylo

Psychedelic-inspired medicine to treat mental illness

27 employees · est. 2021 · Australia

CB Therapeutics is the older company (2015 vs 2021).

Side-by-Side Comparison

CB Therapeutics Psylo
Founded
2015 older 2021
Headquarters
Carlsbad, United States Australia
Employees
15 27
Industry
Biotechnology, Health and Wellness Biotechnology
Funding Stage
Series A Seed
Total Funding
$7.62M $14.10M
Funding Rounds
7 3
Services
Development of rare compounds using synthetic biology, Production of cannabinoids, tryptamines, and peptides, AI-driven biosynthesis platform for enzyme and pathway design, Creation of animal-free food ingredients, Research and development for non-opioid pain management Not tracked yet
Target Customers
Pharmaceutical Companies, Biotechnology Firms, Food and Beverage Industry, Mental Health Research Institutions, Wellness and Supplement Manufacturers Not tracked yet
Taxonomy
Synthetic Biology, Bio-engineering, Synthetic Genomics, Tryptamines, Cannabinoids, Neuroscience, Mental Healthcare, Phytochemicals, Cellular Production Drug Development, Psychedelics, Mental Illness, Medication, SSRI, Clinical Trials, Pharmaceuticals, Psychedelic Medicine, Novel Molecules, Mental Health, Treatment, Psychiatry, Innovation
Website
cbthera.com psylo.bio
CB Therapeutics logo

About CB Therapeutics

CB Therapeutics, founded in 2015 and headquartered in the United States, is at the forefront of biotechnology innovation. Specializing in high-value molecules and rare ingredients, their proprietary SynBio platforms leverage synthetic genomics and bio-engineering to produce complex compounds using y...

Psylo logo

About Psylo

Psylo is a biotechnology startup founded in 2021 and headquartered in Australia. The company's slogan, "Psychedelic-inspired medicine to treat mental illness," reflects its focus on developing next-generation psychedelics as improved treatments for mental illness, aiming to provide alternatives to c...

We will tell you when either one moves

BounceWatch watches CB Therapeutics and Psylo for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at CB Therapeutics and Psylo — by email.

Frequently Asked Questions

CB Therapeutics — CB Therapeutics produces high value molecules, compounds and rare ingredients with novel, proprietary SynBio platforms. . Psylo — Psychedelic-inspired medicine to treat mental illness. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
CB Therapeutics has raised $7.62M while Psylo has raised $14.10M.
CB Therapeutics and Psylo operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare CB Therapeutics with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at CB Therapeutics on 11 Sep 2024, and Psylo on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy